CAR T-Cell Therapy: Delving Into Evolving Topics, Critical Aspects of Management, and Practice-Changing Data

Engage with this series of 6 ClinicalThought expert commentaries designed to keep you up to date over time with the latest findings in CAR T-cell therapy. A downloadable slideset based on the commentaries will help apply the education in the clinic or in your own presentations.
Matthew J. Frigault, MD

Downloadable Slideset

Review expert insights on incorporating CAR T-cell therapies into management of hematologic malignancies, including optimization of real-world patients, multidisciplinary management of toxicities, patient and caregiver education, and emerging data on the most promising investigational strategies.

Matthew J. Frigault, MD Released: March 24, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Celgene Corporation
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue